Keyphrases
Tumor
82%
Dutch
59%
Pediatric
43%
Childhood Cancer Survivors
41%
Pediatric Patients
37%
Pediatric Leukemia
34%
Acute Lymphoblastic Leukemia
33%
Overall Survival
31%
Wilms Tumor
31%
Acute Myeloid Leukemia
28%
Neuroblastoma
28%
Children with Cancer
28%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
27%
High Risk
27%
Childhood Cancer
25%
Pediatric Oncology
24%
Netherlands
24%
Event-free Survival
23%
Confidence Interval
20%
Older Adults
20%
Graft-versus-host Disease (GvHD)
19%
Glioblastoma
19%
Glioma
19%
Health-related Quality of Life
18%
Pediatric Acute Lymphoblastic Leukemia
18%
Chemotherapy
18%
Hematopoietic Stem Cell Transplantation
18%
Central Nervous System Tumors
17%
Melanoma
17%
Working Diagnosis
17%
Diffuse Intrinsic Pontine Glioma
17%
Meta-analysis
16%
Cancer Treatment
16%
Hematopoietic Cell Transplantation
16%
Oncology
15%
Survivors
15%
Childhood Acute Lymphoblastic Leukemia
15%
Radiotherapy
15%
Minimal Residual Disease
15%
Pediatric Cancer Patients
15%
Risk Factors
14%
Pheochromocytoma
14%
Tumor Subtype
14%
T Cells
14%
Cancer Types
13%
Clinical Practice Guidelines
13%
Diffuse Glioma
13%
Paraganglioma
13%
Prognostic Factors
12%
Leukemia
12%
Cancer Genome Atlas
11%
Phase II Trial
11%
Survival Rate
11%
Clinical Outcomes
11%
Pharmacokinetics
11%
Hazard Ratio
11%
Pediatric Cancer
11%
High-risk Neuroblastoma
11%
Childhood Cancer Survivor Study
11%
Randomized Controlled Trial
10%
Renal Tumor
10%
Leukemia Patients
10%
Molecular Analysis
10%
Adjuvant Therapy
10%
Isocitrate Dehydrogenase 1 (IDH1)
10%
Newly Diagnosed
10%
In Cancer
10%
Clinical Trials
10%
Medulloblastoma
9%
Vincristine-induced Peripheral Neuropathy
9%
Late Effects
9%
Systematic Meta-analysis
9%
Population Pharmacokinetics
9%
European Organizations
9%
Risk Stratification
9%
BCP-ALL
9%
Molecular Characterization
9%
Pediatric Renal Tumors
9%
Treatment Outcome
9%
Relapsed or Refractory Acute Myeloid Leukemia
9%
Relapsed or Refractory
9%
Immunohistochemistry
8%
Odds Ratio
8%
Targeted Therapy
8%
COVID-19 Pandemic
8%
Phase II Study
8%
Healthcare Professionals
8%
Adult Cancer
8%
Pembrolizumab
8%
Renal Cell Carcinoma
8%
RNA Sequencing (RNA-seq)
8%
DNA Methylation (DNAm)
8%
Pediatric Tumors
8%
Programmed Death-ligand 1 (PD-L1)
7%
Stage III Melanoma
7%
Antithymocyte Globulin
7%
Population-based Study
7%
Malignancy
7%
Improved Outcomes
7%
COVID-19
7%
Medicine and Dentistry
Neoplasm
100%
Pediatrics
79%
Childhood Cancer
77%
Malignant Neoplasm
72%
Acute Lymphoblastic Leukemia
42%
Disease
40%
Diagnosis
35%
Acute Myeloid Leukemia
34%
Wilms' Tumor
32%
Ganglioneuroblastoma
29%
Melanoma
29%
Pediatrics Patient
29%
Chemotherapy
28%
Overall Survival
27%
Pediatric Acute Myeloid Leukemia
26%
Ganglioglioma
24%
Systematic Review
24%
Immunotherapy
23%
Adolescence
23%
Oncology
22%
Event Free Survival
21%
Kidney Tumour
21%
Recurrent Disease
18%
Hematopoietic Cell
18%
Hematopoietic Stem Cell Transplantation
17%
Pediatric Cancer
17%
Central Nervous System Tumor
16%
Minimal Residual Disease
15%
Biological Marker
14%
Radiation Therapy
14%
Clinical Trial
14%
B Cell
14%
Leukemia
13%
Glioblastoma
12%
T Cell
12%
Quality of Life
12%
Cell Transplantation
12%
Survival Rate
12%
Dexamethasone
11%
Central Nervous System
11%
Cancer
11%
Cancer Treatment
11%
COVID-19
11%
Risk Stratification
11%
Pheochromocytoma
11%
Precursor
10%
Paraganglioma
10%
Magnetic Resonance Imaging
10%
Hazard Ratio
10%
Adjuvant Therapy
10%
Prognostic Factor
9%
Organoid
9%
Immunohistochemistry
9%
Targeted Therapy
9%
Meta-Analysis
9%
Cancer Therapy
8%
Immunity
8%
Rhabdomyosarcoma
8%
DNA Methylation
8%
Surgery
8%
Gene Expression
8%
Metastatic Carcinoma
8%
Pembrolizumab
8%
In Vitro
8%
Pontine Glioma
8%
Supportive Care
8%
Medulloblastoma
8%
Transplantation
8%
Randomized Controlled Trial
7%
Vincristine
7%
Soft Tissue Sarcoma
7%
Acute Myelogenous Leukemia
7%
Retrospective Study
7%
Cohort Analysis
7%
Adverse Event
7%
Odds Ratio
7%
RNA Sequence
7%
Tumor Cell
7%
Breast Cancer
7%
Late Effect
6%
Placebo
6%
Cord Blood Stem Cell Transplantation
6%
Prevalence
6%
Clear Cell Renal Cell Carcinoma
6%
Fertility Preservation
6%
Retrospective Cohort Study
6%
Gene Fusion
6%
Methylation
6%
Tumor Microenvironment
6%
Morphology
6%
The Cancer Genome Atlas
6%
Infection
6%
Neuropathy
5%
Low and Middle Income Countries
5%
Arm
5%
Intracranial Tumor
5%
Recurrence Free Survival
5%
Connective Tissue Cancer
5%
Cancer in Young Adults
5%
Metachromatic Leukodystrophy
5%